BIG PHARMA EARNINGS WATCH: BRISTOL-MYERS SQUIBB
Aug 6, 2020
Brand Name Drug Company Completes Sweep of Big Pharma Giants Who Beat Wall… Read More
© 2026 CSRXP- All Rights Reserved
Blog Posts
DOSE OF REALITY: UNPACKING THE REBATE RULE’S BIG PHARMA ORIGINS
Aug 3, 2020
Little Surprise Big Pharma Bailout That Would Hike Medicare Premiums Was A… Read More
BIG PHARMA EARNINGS WATCH: ABBVIE & MERCK
Jul 31, 2020
Brand Name Drug Companies Continue Streak of Beating Wall Street Expectations… Read More
Big Pharma Earnings Watch: AstraZeneca & Eli Lilly
Jul 31, 2020
Brand Name Drug Companies See Soaring Profits After Hiking Prices Today… Read More
BIG PHARMA EARNINGS WATCH: SANOFI
Jul 29, 2020
Big Pharma Giant Sees Profits Jump After July Price Hikes Big Pharma giant… Read More
BIG PHARMA EARNINGS WATCH: PFIZER & AMGEN
Jul 29, 2020
Brand Name Big Pharma Giants Surpass Expectations After Hiking Prices New… Read More
THEY SAID IT! COVERAGE HIGHLIGHTS REVIVED REBATE RULE AN UNWORKABLE BIG PHARMA BAILOUT
Jul 28, 2020
Reception of Misguided Reboot Focuses on Premium Increases, Cost to Taxpayers,… Read More
THEY SAID IT: GOP AND CONSERVATIVE LEADERS CONCERNED WITH NEGATIVE IMPACT OF REBATE RULE
Jul 22, 2020
HHS Secretary, Republican Lawmakers, Right-of-Center Policy Experts and… Read More
BIG PHARMA EARNINGS WATCH: NOVARTIS
Jul 22, 2020
Brand Name Drug Company Beats Earnings Forecasts After Repeatedly Hiking… Read More
DOSE OF REALITY: BIG PHARMA STICKS WITH PRICE-HIKING “BUSINESS AS USUAL” DURING PANDEMIC
Jul 20, 2020
AMERICAN VOTERS OVERWHELMINGLY SUPPORT MARKET-BASED SOLUTIONS TO HOLD DRUG… Read More
DOSE OF REALITY: REBATE RULE WOULD HAND BIG PHARMA A MASSIVE BAILOUT AT TREMENDOUS COST TO SENIORS & TAXPAYERS
Jul 20, 2020
Policymakers Should Focus On Market-Based Solutions To Hold Drug Companies… Read More
BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON
Jul 16, 2020
Price Hikes Fuel Q2 Earnings Beat For Brand Name Giant As millions of… Read More